|
JP5442449B2
(ja)
|
2006-12-22 |
2014-03-12 |
アステックス、セラピューティックス、リミテッド |
新規化合物
|
|
EP2114941B1
(en)
|
2006-12-22 |
2015-03-25 |
Astex Therapeutics Limited |
Bicyclic heterocyclic compounds as fgfr inhibitors
|
|
CA2934114A1
(en)
*
|
2007-06-12 |
2008-12-18 |
Achaogen, Inc. |
Antibacterial agents
|
|
GB0720038D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New compounds
|
|
GB0720041D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New Compounds
|
|
WO2009067493A2
(en)
*
|
2007-11-19 |
2009-05-28 |
Envivo Pharmaceuticals, Inc. |
1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
|
|
RU2527177C2
(ru)
|
2007-12-20 |
2014-08-27 |
Энвиво Фармасьютикалз, Инк. |
Четырехзамещенные бензолы
|
|
EP2257536A4
(en)
|
2008-02-14 |
2011-03-23 |
Amira Pharmaceuticals Inc |
CYCLIC DIARYL ETHERS AS ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
|
|
US8426449B2
(en)
|
2008-04-02 |
2013-04-23 |
Panmira Pharmaceuticals, Llc |
Aminoalkylphenyl antagonists of prostaglandin D2 receptors
|
|
UA103319C2
(en)
|
2008-05-06 |
2013-10-10 |
Глаксосмитклайн Ллк |
Thiazole- and oxazole-benzene sulfonamide compounds
|
|
GB0810902D0
(en)
|
2008-06-13 |
2008-07-23 |
Astex Therapeutics Ltd |
New compounds
|
|
WO2009158369A1
(en)
*
|
2008-06-25 |
2009-12-30 |
Schering Corporation |
Synthesis and use of heterocyclic antibacterial agents
|
|
CA2729292C
(en)
|
2008-07-03 |
2013-09-03 |
Amira Pharmaceuticals, Inc. |
Phenoxyphenyl sulfide, sulfinyl and sulfonyl antagonists of prostaglandin d2 receptors
|
|
US8273900B2
(en)
|
2008-08-07 |
2012-09-25 |
Novartis Ag |
Organic compounds
|
|
US8372885B2
(en)
*
|
2008-09-17 |
2013-02-12 |
Novartis Ag |
Organic compounds and their uses
|
|
WO2010057118A2
(en)
|
2008-11-17 |
2010-05-20 |
Amira Pharmaceuticals, Inc. |
Heterocyclic antagonists of prostaglandin d2 receptors
|
|
GB0906472D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
|
GB0906470D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
|
WO2011005355A1
(en)
*
|
2009-05-07 |
2011-01-13 |
Achaogen, Inc. |
Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria
|
|
FR2950057B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
FR2950056B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
WO2011047323A2
(en)
|
2009-10-16 |
2011-04-21 |
Rib-X Pharmaceuticals, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
BR112012008759A2
(pt)
|
2009-10-16 |
2020-08-25 |
Rib-X Pharmaceuticals, Inc. |
compostos antimicrobianos e métodos de fabricação e uso dos mesmos
|
|
JP6267863B2
(ja)
|
2009-10-16 |
2018-01-24 |
メリンタ セラピューティクス，インコーポレイテッド |
抗微生物性化合物および抗微生物性化合物の製造方法および使用方法
|
|
JP2013516475A
(ja)
|
2010-01-06 |
2013-05-13 |
アミラ ファーマシューティカルズ，インク． |
Ｄｐ２アンタゴニストおよびその使用
|
|
SG184958A1
(en)
*
|
2010-04-20 |
2012-11-29 |
Taisho Pharmaceutical Co Ltd |
Novel hydroxamic acid derivative
|
|
US8835472B2
(en)
*
|
2010-09-02 |
2014-09-16 |
Boehringer Ingelheim International Gmbh |
Compounds, pharmaceutical compositions and uses thereof
|
|
WO2012031298A2
(en)
|
2010-09-03 |
2012-03-08 |
Duke University |
Ethynylbenzene derivatives
|
|
AR083760A1
(es)
*
|
2010-11-10 |
2013-03-20 |
Achaogen Inc |
Agentes antibacterianos y composiciones farmaceuticas
|
|
PT2697229T
(pt)
|
2011-04-15 |
2018-04-13 |
Melinta Therapeutics Inc |
Compostos antimicrobianos e seus métodos de fabrico e de utilização
|
|
US8883819B2
(en)
|
2011-09-01 |
2014-11-11 |
Irm Llc |
Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
|
|
US20150203444A1
(en)
|
2011-09-12 |
2015-07-23 |
Achaogen, Inc. |
Polymorphs of n-((s)-3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-(((1r,2r)-2-(hydroxymethyl)cyclopropyl)buta-1,3-diynyl)benzamide
|
|
CN102603690A
(zh)
*
|
2012-01-17 |
2012-07-25 |
凯莱英医药集团（天津）股份有限公司 |
一种一锅法制备四氢吡喃-4-甲酸及其衍生物的方法
|
|
US9290500B2
(en)
|
2012-02-17 |
2016-03-22 |
Millennium Pharmaceuticals, Inc. |
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
|
|
WO2013170030A1
(en)
*
|
2012-05-09 |
2013-11-14 |
Achaogen, Inc. |
Antibacterial agents
|
|
EP2847168A1
(en)
|
2012-05-10 |
2015-03-18 |
Achaogen, Inc. |
Antibacterial agents
|
|
JP6139272B2
(ja)
*
|
2012-06-01 |
2017-05-31 |
株式会社半導体エネルギー研究所 |
発光素子の作製方法
|
|
US9073921B2
(en)
|
2013-03-01 |
2015-07-07 |
Novartis Ag |
Salt forms of bicyclic heterocyclic derivatives
|
|
WO2014165075A1
(en)
|
2013-03-12 |
2014-10-09 |
Achaogen, Inc. |
Antibacterial agents
|
|
LT2975022T
(lt)
|
2013-03-15 |
2019-07-25 |
Fujifilm Toyama Chemical Co., Ltd. |
Naujas hidroksamo rūgšties darinys arba jo druska
|
|
GB201307233D0
(en)
*
|
2013-04-22 |
2013-05-29 |
Vib Vzw |
Compounds and uses thereof
|
|
WO2015002994A2
(en)
|
2013-07-02 |
2015-01-08 |
Millennium Pharmaceuticals, Inc. |
Heteroaryl compounds useful as inhibitors of sumo activating enzyme
|
|
WO2015024016A2
(en)
|
2013-08-16 |
2015-02-19 |
Duke University |
2-piperidinyl substituted n,3-dihydroxybutanamides
|
|
US10189786B2
(en)
|
2013-08-16 |
2019-01-29 |
Duke University |
Antibacterial compounds
|
|
US10647664B2
(en)
|
2013-08-16 |
2020-05-12 |
Duke University |
Substituted hydroxamic acid compounds
|
|
MX2016003046A
(es)
|
2013-09-09 |
2016-09-08 |
Melinta Therapeutics Inc |
Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos.
|
|
EP3039025A4
(en)
|
2013-09-09 |
2017-05-31 |
Melinta Therapeutics, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
AR097617A1
(es)
|
2013-09-13 |
2016-04-06 |
Actelion Pharmaceuticals Ltd |
Derivados antibacterianos del 2h-indazol
|
|
TW201602065A
(zh)
*
|
2013-10-18 |
2016-01-16 |
大正製藥股份有限公司 |
異羥肟酸衍生物
|
|
JP2016210682A
(ja)
*
|
2013-10-18 |
2016-12-15 |
大正製薬株式会社 |
ヒドロキサム酸誘導体
|
|
JP2016210683A
(ja)
*
|
2013-10-18 |
2016-12-15 |
大正製薬株式会社 |
ヒドロキサム酸誘導体
|
|
JP6407288B2
(ja)
|
2013-12-19 |
2018-10-17 |
イドーシア ファーマシューティカルズ リミテッドＩｄｏｒｓｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ |
抗菌性１ｈ−インダゾール及び１ｈ−インドール誘導体
|
|
US9539305B1
(en)
|
2014-03-14 |
2017-01-10 |
Fleurir Abx Llc |
Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
|
|
EP3143007B1
(en)
*
|
2014-05-16 |
2018-07-11 |
Idorsia Pharmaceuticals Ltd |
Antibacterial quinazoline-4(3h)-one derivatives
|
|
KR102567244B1
(ko)
*
|
2014-06-12 |
2023-08-16 |
세다르스-신나이 메디칼 센터 |
암을 치료하는 조성물 및 방법
|
|
HUE045748T2
(hu)
|
2014-07-01 |
2020-01-28 |
Millennium Pharm Inc |
Heteroaril vegyületek mint SUMO aktiváló enzimek inhibitorai
|
|
WO2016039432A1
(ja)
|
2014-09-12 |
2016-03-17 |
富山化学工業株式会社 |
新規なヒドロキサム酸誘導体および抗菌性物質を組み合わせて使用する方法
|
|
JPWO2016039433A1
(ja)
|
2014-09-12 |
2017-06-22 |
富山化学工業株式会社 |
新規なヒドロキサム酸誘導体またはその塩を含有する医薬組成物
|
|
CN104341476A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-肌苷型多靶点抗菌化合物及其制法和用途
|
|
CN104341475A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN104327140B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁唑烷酮-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN104262433B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-腺苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN104231024B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-肌苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN105777464B
(zh)
*
|
2014-12-26 |
2020-09-29 |
中国科学院上海药物研究所 |
异羟肟酸衍生物及其制备方法和应用
|
|
JP6208161B2
(ja)
|
2015-02-06 |
2017-10-04 |
信越化学工業株式会社 |
非対称共役ジイン化合物の製造方法及びこれを用いたｚ，ｚ−共役ジエン化合物の製造方法
|
|
CN107922418A
(zh)
|
2015-03-11 |
2018-04-17 |
梅琳塔治疗公司 |
抗微生物化合物及制备和使用所述化合物的方法
|
|
WO2017083434A1
(en)
|
2015-11-09 |
2017-05-18 |
Forge Therapeutics, Inc. |
Pyrone based compounds for treating bacterial infections
|
|
WO2017083431A2
(en)
|
2015-11-09 |
2017-05-18 |
Forge Therapeutics, Inc. |
Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
|
|
RU2018124788A
(ru)
*
|
2015-12-08 |
2020-01-15 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Замещенные бензазиноны в качестве антибактериальных соединений
|
|
CN105669750B
(zh)
*
|
2016-03-01 |
2018-04-03 |
中国医学科学院医药生物技术研究所 |
新型锌离子螯合剂及其制备和在抗革兰氏阴性菌感染中的应用
|
|
CA3016341A1
(en)
*
|
2016-03-07 |
2017-09-14 |
Merck Sharp & Dohme Corp. |
Bicyclic aryl monobactam compounds and methods of use thereof for the treatment of bacterial infections
|
|
EP3426674A4
(en)
|
2016-03-09 |
2019-08-14 |
Blade Therapeutics, Inc. |
CYCLIC KETO AMID COMPOUNDS AS CALPAIN MODULATORS AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
CA3021152A1
(en)
*
|
2016-04-18 |
2017-10-26 |
Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. |
Inhibitors of meprin alpha and beta
|
|
EP3448375B1
(en)
*
|
2016-04-25 |
2023-09-27 |
Duke University |
Benzoylglycine derivatives and methods of making and using same
|
|
JP2019515041A
(ja)
|
2016-05-06 |
2019-06-06 |
メリンタ セラピューティクス、 インコーポレイテッドＭｅｌｉｎｔａ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
抗菌剤ならびにそれを作製および使用する方法
|
|
WO2017223349A1
(en)
|
2016-06-23 |
2017-12-28 |
Achaogen, Inc. |
Antibacterial agents
|
|
EP3481835A4
(en)
|
2016-07-05 |
2020-02-26 |
Blade Therapeutics, Inc. |
CALPAIN MODULATORS AND THERAPEUTIC USE THEREOF
|
|
SG10201912574WA
(en)
|
2016-09-28 |
2020-02-27 |
Blade Therapeutics Inc |
Calpain modulators and therapeutic uses thereof
|
|
WO2018115421A1
(en)
*
|
2016-12-23 |
2018-06-28 |
Intervet International B.V. |
Compounds useful for treating a mannheimia haemolytica or histophilus somni infection
|
|
JP7082445B2
(ja)
|
2016-12-23 |
2022-06-08 |
インターベット インターナショナル ベー． フェー． |
ウシ又はブタの呼吸器疾患を治療するための化合物
|
|
MX2021011775A
(es)
|
2017-04-26 |
2023-01-10 |
Basilea Pharm Int Ag |
Procesos para la preparacion de furazanobencimidazoles y formas cristalinas de estos.
|
|
EP3621962A4
(en)
|
2017-05-10 |
2020-12-09 |
Forge Therapeutics, Inc. |
ANTIBACTERIAL COMPOUNDS
|
|
WO2018208987A2
(en)
*
|
2017-05-10 |
2018-11-15 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
AU2018306420B2
(en)
*
|
2017-07-27 |
2024-02-15 |
BioMendics, LLC |
Substituted tolans for the modulation of microbial colonization
|
|
WO2019040404A1
(en)
*
|
2017-08-21 |
2019-02-28 |
Microbiotix, Inc. |
METABOLIC-STABLE METABOLIC-N-ACYLAMINOOXADIAZOLES USEFUL AS ANTIBACTERIAL AGENTS
|
|
BR112020016270A2
(pt)
*
|
2018-02-10 |
2020-12-15 |
Kbp Biosciences Co., Ltd. |
Composto atuando como antibióticos
|
|
WO2019178129A1
(en)
|
2018-03-13 |
2019-09-19 |
Shire Human Genetic Therapies, Inc. |
Substituted imidazopyridines as inhibitors of plasma kallikrein and uses thereof
|
|
WO2020061103A1
(en)
|
2018-09-18 |
2020-03-26 |
Nikang Therapeutics, Inc. |
Fused tricyclic ring derivatives as src homology-2 phosphatase inhibitors
|
|
CA3113226A1
(en)
|
2018-09-20 |
2020-03-26 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
US11179383B2
(en)
|
2018-10-30 |
2021-11-23 |
Gilead Sciences, Inc. |
Compounds for inhibition of α4β7 integrin
|
|
ES3013256T3
(en)
|
2018-10-30 |
2025-04-11 |
Gilead Sciences Inc |
Imidazo[1,2-a]pyridine derivatives as alpha4beta7 integrin inhibitors for the treatment of inflammatory diseases
|
|
KR102630416B1
(ko)
|
2018-10-30 |
2024-02-01 |
길리애드 사이언시즈, 인코포레이티드 |
알파4베타7 인테그린 억제제로서의 퀴놀린 유도체
|
|
AU2019373242B2
(en)
|
2018-10-30 |
2023-07-13 |
Gilead Sciences, Inc. |
Compounds for inhibition of alpha 4 beta 7 integrin
|
|
WO2020102572A1
(en)
*
|
2018-11-14 |
2020-05-22 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
TW202039478A
(zh)
*
|
2018-11-21 |
2020-11-01 |
日商大正製藥股份有限公司 |
新穎咪唑衍生物
|
|
CN114222730B
(zh)
|
2019-08-14 |
2024-09-10 |
吉利德科学公司 |
用于抑制α4β7整合素的化合物
|
|
US11370803B2
(en)
|
2019-09-18 |
2022-06-28 |
Takeda Pharmaceutical Company Limited |
Heteroaryl plasma kallikrein inhibitors
|
|
PT4031547T
(pt)
|
2019-09-18 |
2024-08-27 |
Takeda Pharmaceuticals Co |
Inibidores de calicreína plasmática e utilizações dos mesmos
|
|
CN110563611B
(zh)
|
2019-09-19 |
2021-02-02 |
中国医学科学院医药生物技术研究所 |
一种异羟肟酸类衍生物及其制备方法和应用
|
|
WO2021138391A1
(en)
|
2019-12-30 |
2021-07-08 |
Tyra Biosciences, Inc. |
Indazole compounds
|
|
WO2021195260A1
(en)
|
2020-03-25 |
2021-09-30 |
Forge Therapeutics, Inc. |
Lpxc inhibitor and methods of making
|
|
IL298324A
(en)
|
2020-06-10 |
2023-01-01 |
Aligos Therapeutics Inc |
Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
|
|
CR20230576A
(es)
|
2021-06-14 |
2024-04-05 |
Scorpion Therapeutics Inc |
Derivados de la urea que pueden ser utilizados para tratar el cáncer
|
|
CA3224494A1
(en)
|
2021-07-09 |
2023-01-12 |
Koen Vandyck |
Anti-viral compounds
|
|
CN117751113A
(zh)
*
|
2021-08-05 |
2024-03-22 |
浙江海正药业股份有限公司 |
芳香乙炔类衍生物及其制备方法和用途
|
|
WO2023043816A1
(en)
|
2021-09-17 |
2023-03-23 |
Aligos Therapeutics, Inc. |
Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
|
|
CA3233328A1
(en)
|
2021-09-28 |
2023-04-06 |
Min Teng |
Lpxc inhibitors and uses thereof
|
|
WO2023118558A1
(en)
*
|
2021-12-24 |
2023-06-29 |
Intervet International B.V. |
Process of the preparation of hydroxylamine derivatives
|
|
US20260092055A1
(en)
*
|
2022-09-28 |
2026-04-02 |
Zhejiang Hisun Pharmaceutical Co., Ltd. |
Aromatic Acetylene Derivative, Preparation Method Therefor, And Pharmaceutical Use Thereof
|
|
CN115480037B
(zh)
*
|
2022-10-14 |
2023-07-18 |
青岛国泰检测科技有限公司 |
一种污水检测方法
|
|
CN115598253B
(zh)
*
|
2022-10-25 |
2025-02-21 |
无锡紫杉药业股份有限公司 |
一种多西他赛原料药中dcc和dcu残留的检测方法
|
|
KR20250121114A
(ko)
|
2022-12-16 |
2025-08-11 |
아스트라제네카 아베 |
2,6,9-삼치환된 퓨린
|
|
CN116730870B
(zh)
|
2023-08-08 |
2023-10-13 |
中国医学科学院医药生物技术研究所 |
异羟肟酸类化合物或其可药用盐、及其用途和制备方法
|
|
CN117586278A
(zh)
*
|
2023-11-27 |
2024-02-23 |
华北制药集团先泰药业有限公司 |
一种氨苄西林钠杂质及其制备方法
|
|
WO2025155681A1
(en)
*
|
2024-01-19 |
2025-07-24 |
Corteva Agriscience Llc |
Nitrification inhibiting mixtures
|